[Summary]
Our view on Japan Tobacco (JT) is currently neutral. The full-year financial results for the fiscal year ending December 2025 showed increased sales and profits, with revenue increasing 13.4% year on year to 3,467,675 million yen, operating income increasing 175.9% year on year to 867,038 million yen, and profit attributable to owners of the parent company increasing 184.6% year on year to 510,175 million yen. Although the apparent profit growth includes a rebound from losses related to Canadian litigation in the previous fiscal year, core earnings are strong, with adjusted operating profit increasing 21.5% year on year to 902,207 million yen. Improvements in price and mix, expansion of RRP, and price revisions for processed foods contributed. On the other hand, FY2026 is a phase in which upfront investment in RRP and foreign exchange headwinds are factored in, and the turning point in evaluation will be the balance between maintaining high dividends and growth investment.
Overview
JT is a global tobacco company that sells products in more than 130 countries and regions, and also operates a processed food business in Japan. From the third quarter of 2025, the pharmaceutical business will be classified as discontinued operations, and the current continuing operations will be centered on the tobacco business and processed food business. The core points of the current full-year financial results are that, despite the temporary factors, the company secured an increase in core earnings and maintained its high dividend policy.
Sales: 3,467,675 million yen Operating income: 867,038 million yen Final profit: 510,175 million yen YoY: Increase in sales and profit
Although the apparent increase in operating income is large due to temporary factors, core earnings are also continuing to increase.
Financial Highlights (Simple Table)
| Indicators | Contents |
|---|---|
| Sales | 3,467,675 million yen, 13.4% increase compared to the same period last year |
| Operating income | 867,038 million yen, 175.9% increase |
| Final profit | 510,175 million yen, 184.6% increase |
| Factor 1 | Price/mix improvement and RRP growth in the tobacco business |
| Factor 2 | Effect of price revisions on processed foods and elimination of one-time losses in the previous fiscal year |
The indicator that should be looked at as a supplementary indicator is adjusted operating profit, which in FY2025 was 902,207 million yen, an increase of 21.5% compared to the same period last year, and an increase of 24.9% on a constant exchange basis.
What happened (most important)
Quantity
In the tobacco business, in addition to an increase in the volume of Combustibles, growth in RRP pushed up the overall results. According to the financial results briefing materials, RRP sales volume and RRP-related sales revenue in fiscal 2025 both increased by 20% over the previous year, and Ploom's sales volume increased by nearly 40%.
The growth in volume is not a temporary phenomenon, and is largely due to structural factors such as expanding sales of Ploom domestically and capturing demand for tobacco, including from overseas.
price
JT says that in FY2025, all clusters will see positive price/mix effects. The quality of profit is not bad, not only in quantity but also in unit price improvement.
Furthermore, in February 2026, retail price revisions were approved in line with a review of the taxation system for heated tobacco. Since April 1st, prices have been raised for a total of 37 brands of cigarette sticks for Plume and cigarette capsules for Wiz, and the penetration of price pass-through will be a focus in 2026.
Cost
On the cost side, RRP investment continues to expand. The company plans to invest approximately 800 billion yen in RRP over the three years from 2026 to 2028, and in the short term, sales promotion and development investments are likely to weigh on profit margins.
In the processed food business, profit increased in fiscal 2025 as the effects of price revisions outweighed the soaring raw material costs, but in the company's fiscal 2026 plan, adjusted operating income is expected to be 8 billion yen, a decrease of 600 million yen from the previous year, even with increased sales. The food side is a defensive source of income, but its ability to withstand cost increases is limited.
Exchange
Adjusted operating profit for FY2025 was negatively affected by the depreciation of currencies in emerging countries. The outlook for fiscal 2026 also incorporates depreciation of emerging countries' currencies against the yen and appreciation of cost-related currencies as headwinds.
Because the tobacco business's profit sources are widely dispersed overseas, even if volume and prices are strong, foreign exchange fluctuations will greatly affect profits when converted to yen. This is a structural variable factor.
Separating structural and temporary factors
The reason for the large jump in operating profit for FY2025 was the rebound from the provision for Canadian litigation losses recorded in the previous year. Therefore, looking only at the 175.9% year-on-year increase in operating income is misleading.
On the other hand, the over 20% increase in adjusted operating profit, over 20% growth in RRP, and improvements in price and mix indicate improvement in core earnings. When looking at stock prices, this is more important than apparent profits.
Latest materials (3 months)
On February 12, 2026, JT announced its fiscal year 2025 financial results and management plan 2026. The company's plans for fiscal 2026 are revenue of 3,697 billion yen, adjusted operating profit of 955 billion yen, operating profit of 921 billion yen, and profit attributable to owners of the parent company of 570 billion yen. The annual dividend forecast was set at 242 yen, and the target payout ratio was set at around 75%.
February 12th was also the day when Yahoo Finance's stock price data hit a year-to-date high of 6,182 yen. It appears that at least on the day of the announcement, it was easy to receive a positive evaluation because financial results, return policy, and medium-term profit growth policy were announced at the same time.
On February 26, 2026, the list price revision was approved in line with the review of the taxation system for heated tobacco. Prices for Ploom sticks and with capsules have been raised since April 1st, and the domestic tobacco business has entered a phase where not only quantity but also unit price management will determine short-term performance.
On March 3, 2026, we launched Nordic Spirit, a modern oral product that does not require fire, in Japan, and began nationwide rollout on April 6. The fact that the company has started testing RRP categories other than heating types in the domestic market is significant as a step towards reducing dependence on Ploom.
On April 8, 2026, it was announced that the ``Mevius E Series 12'' cigarettes would be released nationwide from May 25 for 500 yen. In addition to heated products, the price range and product portfolio of paper rolls continues to be adjusted.
The next major confirmation is the first quarter financial results scheduled for May 8, 2026. The short-term focus will be on how quickly the profit increase plan announced in February can be confirmed through price revisions and the introduction of new products in April.
Business structure
Source of revenue
JT's main source of revenue is overwhelmingly its tobacco business. In fiscal 2025, the company's tobacco product sales revenue was 3,184.4 billion yen, and the tobacco business's adjusted operating profit was 952.2 billion yen.
On the other hand, the processed food business's sales revenue in FY2025 is 159.5 billion yen, and adjusted operating profit is 8.6 billion yen, making the business scale and profit scale smaller than that of tobacco. Although food is a source of diversification, the tobacco business remains the driving force behind company-wide profits.
Profit margin
Operating profit margin on a continuing operations basis for fiscal 2025 was 25.0%. Since the apparent operating profit margin includes temporary factors, adjusted operating profit is more suitable for understanding the actual situation, but the company still has a high profit structure.
The company's high profit margins are supported by its brand power, global sales network, and ability to implement price revisions.
Strengths
The JT Group sells tobacco products in more than 130 countries and regions, and based on fiscal 2024 results, it is the third largest company in the world, excluding China Monopoly Corporation. It also has a high share in major markets, with a 41.2% share in Japan based on total demand.
In addition, it has the advantage of being able to invest in RRP while earning profits from Combustibles. It is easy to balance short-term profits with medium-term portfolio conversion.
Weaknesses
Its weaknesses are clear: it is easily influenced by regulations, taxes, and exchange rates. While the tobacco industry has the ability to pass on prices, tax changes and sales regulations have a direct impact on volume and product strategy.
Also, although RRP is increasing, it will take time to recover the investment. At this stage, growth investment is largely taking the lead.
Implications for stock prices
Positive
In fiscal 2025, not only apparent profits but also adjusted operating profits increased by over 20%. It is easy to appreciate that price/mix improvement and RRP growth are working at the same time.
In addition, the annual dividend forecast for FY2026 of 242 yen has been maintained, and according to Yahoo Finance data as of May 1, the expected dividend yield is 4.11%. It remains a stock that can be expected to deliver both profit growth and income.
Negative
On the other hand, FY2026 is also the year in which RRP investment continues and foreign exchange headwinds are factored in. The adjusted operating profit growth rate in the company's plan is 7.9%, or 8.9% on a constant currency basis, which is slower than the growth rate for FY2025.
Profit plans for processed foods are also somewhat weak, and the company as a whole will become even more dependent on the tobacco business.
Weaving
According to Yahoo Finance data as of May 1st, the stock price was 5,886 yen, the expected PER was 18.33 times, and the actual PBR was 2.56 times. The stock does not feel extremely cheap as a high-dividend stock, and it is easy to see that a certain level of stable growth and return expectations are already reflected in the stock price.
The market is interpreting the fiscal year 2025 financial results more positively than pessimistically, as the stock has remained in the high range even after hitting a year-to-date high of 6,182 yen on February 12th.
Gap
The future gap lies in the extent to which RRP investment centered on Ploom will lead to profit growth. There is room for the company's evaluation to improve if it not only expands sales but also improves profitability towards its RRP profitability target by 2028.
On the other hand, if sales volume increases but profit growth falls short of the company's plan due to heavy sales promotion costs and exchange rates, high dividends alone will likely limit the upside potential for stock prices.
Short term (6 months)
The biggest short-term factor is the first quarter results on May 8, 2026.
There are three things to look at. The key questions are whether Ploom's volume growth continues, how the April 1st price revision has started to affect domestic profits, and how much depreciation of currencies in emerging countries has cut into profits.
In addition, the nationwide rollout of Nordic Spirit in April and the initial launch of new Mevius products from mid-May will also confirm that the company is strengthening its domestic portfolio.
Mid-term (1 year)
In the medium term, the focus will be on how well the first year of Management Plan 2026 can proceed as planned. The company aims to achieve average annual high single digit growth in adjusted operating profit from 2026 to 2028 on a constant currency basis.
In the tobacco business, the company aims to capture a mid-10% share in the major heat-not-burn market by 2028 and make the RRP business profitable. 2026 is also a year for investment, and it will be important to see signs of improved profitability as well as increased sales.
In terms of finances, the FCF plan for FY2026 is expected to be 530 billion yen, a significant improvement from the FY2025 actual result of 272.7 billion yen. If profit growth and cash generation are compatible, the stability of dividends will be more easily evaluated.
Scenario analysis
Bullish: 30% If Ploom's growth and price revision effects are confirmed from the first quarter and it is able to absorb exchange rate headwinds, the stock price will likely be able to test new highs.
Neutral: 50% Even if the tobacco business is strong, if the RRP investment burden and exchange rate headwinds remain, the stock price is likely to remain flat while maintaining a stable evaluation as a high dividend stock.
Bearish: 20% If volume growth slows down and negative RRP investment and foreign exchange rates become more significant than expected, expectations for profit growth will decline and stock prices will likely adjust.
Risk (simple table)
| Risk | Contents |
|---|---|
| Regulation and Taxation | Changes in tobacco taxes and sales regulations impact volume and pricing strategy |
| Foreign exchange | Weak currencies in emerging countries and high cost currencies put pressure on profits when converted to yen |
| RRP investment | Return on investment may be delayed compared to sales growth |
| Raw materials | Rising procurement costs for processed foods and leaf tobacco |
| Geopolitics | Business operations remain uncertain in some markets such as Russia |
Summary
JT's full-year financial results for the fiscal year ending December 2025 included an increase in core earnings, despite some temporary factors, and the company maintained its high dividend policy. Improvements in price and mix, RRP growth, and price revisions for processed foods were all effective, resulting in solid full-year results.
However, future evaluations will move beyond just being a defensive high-dividend stock, and will focus on whether RRP investment can be converted into profit growth. FY2026 will be a year in which we will confirm the balance between profit growth and upfront investment.
The next point to watch is whether the company's profit increase plan announced in February is actually starting to move forward with the first quarter results on May 8th. The turning point in evaluation is price revisions and new products in the short term, and monetization of RRP in the medium term.